Palvella Therapeutics Inc... (PVLA)
NASDAQ: PVLA
· Real-Time Price · USD
67.45
1.67 (2.54%)
At close: Oct 06, 2025, 2:49 PM
Palvella Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | 1.3M | 20.82M | 40.87M | 42.81M | 41.51M | 21.99M | 1.94M |
Cost of Revenue | n/a | n/a | n/a | 739K | 1.46M | 2.04M | 2.04M | 1.3M | 571K |
Gross Profit | n/a | n/a | 1.3M | 20.08M | 39.41M | 40.77M | 39.48M | 20.7M | 1.36M |
Operating Income | -24.43M | -16.94M | -14.55M | -8.33M | -2.09M | -15.84M | -10.36M | -13.45M | -15.51M |
Interest Income | 1.61M | 1.01M | 710K | 1.09M | 1.58M | 1.85M | 1.4M | 847K | 357K |
Pretax Income | -24.13M | -17.2M | -13.6M | -21.46M | -13.9M | -24.54M | -19.96M | -9.21M | -13.18M |
Net Income | -24.13M | -17.2M | -13.6M | -21.46M | -13.9M | -24.54M | -19.96M | -9.21M | -13.18M |
Selling & General & Admin | 14.94M | 11.58M | 10.11M | 12.63M | 12.9M | 16.18M | 13.85M | 7.75M | 4.06M |
Research & Development | 9.5M | 5.36M | 5.74M | 15.78M | 28.6M | 40.44M | 35.98M | 26.39M | 12.82M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 24.43M | 16.94M | 15.85M | 28.41M | 41.5M | 56.62M | 49.84M | 34.14M | 16.88M |
Interest Expense | 3.63M | 3.08M | 1.86M | 1.86M | 805K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.43M | 16.94M | 15.85M | 29.15M | 42.97M | 58.65M | 51.87M | 35.44M | 17.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.05M | 2.23M | 1.32M | 1.3M | 1.27M | 1.24M | 1.24M | 1.09M | 11.22M |
Shares Outstanding (Diluted) | 11.05M | 2.23M | 1.32M | 1.3M | 1.27M | 1.24M | 1.24M | 1.1M | 11.22M |
EPS (Basic) | -9.49 | -10.63 | -10.66 | -17.17 | -10.78 | -9.4 | -5.69 | 3.01 | -0.62 |
EPS (Diluted) | -9.49 | -10.63 | -10.66 | -17.17 | -10.79 | -9.41 | -5.7 | 3.00 | -0.62 |
EBITDA | -21.56M | -15.18M | -12.79M | -19.92M | -11.63M | -22.51M | -17.92M | -7.91M | -12.61M |
EBIT | -21.56M | -15.18M | -12.79M | -20.66M | -13.09M | -24.54M | -19.96M | -9.21M | -13.18M |
Depreciation & Amortization | n/a | n/a | n/a | 739K | 1.46M | 2.04M | 2.04M | 1.3M | 571K |